Study of Aom0304 for symptomatic hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This trial tests a new drug, Aom0304, for people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) who still have symptoms despite standard treatments. The study aims to see if the drug can improve symptoms and heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with hypertrophic cardiomyopathy (thickened heart muscle) based on specific measurements or family history
- You have symptoms like shortness of breath or chest pain (NYHA class II or III)
- Your heart's pumping function (LVEF) is at least 60%
- You weigh at least 45 kg and your body mass index (BMI) is between 18 and 35
- You can safely undergo exercise tests and have good quality heart ultrasound images
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with HCM (a condition where the heart muscle becomes abnormally thick) to understand how the disease affects them over time in everyday life. The goal is to learn more about treatment outcomes and quality of life for people living with this condition.
This trial tests whether a drug called mavacamten can help people with a specific type of thickened heart muscle (obstructive hypertrophic cardiomyopathy, or oHCM) by improving how the heart uses energy. It aims to understand if this treatment can improve symptoms and function.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This study looks at how hypertrophic cardiomyopathy (HCM) affects people in China in real-world settings. It may help doctors understand the condition better and improve care for patients like you.
This study uses MRI scans to re-examine people with hypertrophic cardiomyopathy (a thickening of the heart muscle) who were part of the original HCMR study. It compares different types of HCM to learn more over time.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.